Biofrontera Analyst Ratings
Biofrontera Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/31/2023 | 102.93% | Benchmark | → $18 | Reiterates | Buy → Buy |
| 07/05/2023 | 102.93% | Benchmark | $140 → $18 | Maintains | Buy |
| 05/15/2023 | -21.08% | Benchmark | → $7 | Reiterates | Buy → Buy |
| 03/09/2023 | -21.08% | Benchmark | → $7 | Reiterates | → Buy |
| 01/31/2023 | -21.08% | Benchmark | $11 → $7 | Reiterates | → Buy |
| 12/15/2021 | 24.01% | Benchmark | → $11 | Initiates Coverage On | → Buy |
| 11/24/2021 | 125.48% | Roth Capital | → $20 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月31日 | 102.93% | 基準 | →$18 | 重申 | 購買→購買 |
| 07/05/2023 | 102.93% | 基準 | $140→$18 | 維護 | 買 |
| 2023年05月15日 | -21.08% | 基準 | →$7 | 重申 | 購買→購買 |
| 03/09/2023 | -21.08% | 基準 | →$7 | 重申 | →購買 |
| 2023年年1月31日 | -21.08% | 基準 | $11→$7 | 重申 | →購買 |
| 2021年12月15日 | 24.01% | 基準 | →$11 | 開始承保 | →購買 |
| 2021年11月24日 | 125.48% | 羅斯資本 | →$20 | 開始承保 | →購買 |
What is the target price for Biofrontera (BFRI)?
Biofrontera(BFRI)的目標價格是多少？
The latest price target for Biofrontera (NASDAQ: BFRI) was reported by Benchmark on August 31, 2023. The analyst firm set a price target for $18.00 expecting BFRI to rise to within 12 months (a possible 102.93% upside). 5 analyst firms have reported ratings in the last year.
基準公司於2023年8月31日報告了Biofrontera(納斯達克：BFRI)的最新目標價。這家分析公司將目標價定為18美元，預計BFRI將在12個月內升至(可能上漲102.93%)。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for Biofrontera (BFRI)?
分析師對Biofrontera(BFRI)的最新評級是多少？
The latest analyst rating for Biofrontera (NASDAQ: BFRI) was provided by Benchmark, and Biofrontera reiterated their buy rating.
納斯達克(Sequoia Capital：BFRI)的最新分析師評級由Benchmark提供，Biofrontera重申其買入評級。
When is the next analyst rating going to be posted or updated for Biofrontera (BFRI)?
Biofrontera(BFRI)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biofrontera, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biofrontera was filed on August 31, 2023 so you should expect the next rating to be made available sometime around August 31, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Biofrontera的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Biofrontera的上一次評級是在2023年8月31日提交的，所以你應該預計下一次評級將在2024年8月31日左右的某個時候公佈。
Is the Analyst Rating Biofrontera (BFRI) correct?
分析師對Biofrontera(BFRI)的評級正確嗎？
While ratings are subjective and will change, the latest Biofrontera (BFRI) rating was a reiterated with a price target of $0.00 to $18.00. The current price Biofrontera (BFRI) is trading at is $8.87, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Biofrontera(BFRI)評級被重申，目標價在0.00美元至18.00美元之間。Biofrontera(BFRI)目前的交易價格為8.87美元，在分析師的預測範圍內。